title: Protection against hydrogen peroxide-induced injury by Z-ligustilide in PC12 cells.
abstract: Z-ligustilide (Z-LIG) is the primary lipophilic compound of the Chinese medicine Danggui (Radix Angelica sinensis). Previous studies demonstrated that Z-LIG had significant neuroprotective potential in both transient and permanent cerebral ischemia, possibly through antioxidant and anti-apoptotic mechanisms. The present study examined the mechanisms of Z-LIG on hydrogen peroxide (H(2)O(2))-induced injury in PC12 cells. Following exposure of the cells to H(2)O(2 )(500 microM), a significant reduction in cell survival and total antioxidant capacity (TAC), as well as increased intracellular reactive oxygen species (ROS), were observed. In addition, H(2)O(2 )treatment significantly upregulated Bax expression, cleaved-caspase 3, and cytosolic cytochrome-c, and decreased Bcl-2 protein levels. Pretreatment of the cells with Z-LIG (0.1, 1.0, 2.5, or 5.0 microg/ml) significantly attenuated H(2)O(2)-induced cell death, attenuated increased intracellular ROS levels, and decreased Bax expression, cleaved-caspase 3, and cytochrome-c. Further, Z-LIG improved cellular TAC and concentration-dependently upregulated Bcl-2 expression. These results demonstrate that Z-LIG has a pronounced protective effect against H(2)O(2)-induced cytotoxicity, at least partly through improving cellular antioxidant defense and inhibiting the mitochondrial apoptotic pathway. These findings suggest that Z-LIG may be useful in the treatment of neurodegenerative disorders in which oxidative stress and apoptosis are mainly implicated.
authors: Department of Pharmacology and Key Laboratory of Drug Targeting, Education Ministry, West China School of Pharmacy, Sichuan University, Chengdu, 610041, People's Republic of China.
authors: Yan
authors: Y
authors: Yu
authors: Jun-Rong
authors: JR
authors: Du
authors: Chen-Yuan
authors: CY
authors: Wang
authors: Zhong-Ming
authors: ZM
authors: Qian
mesh_terms: D015107:4-Butyrolactone / Q000031:analogs & derivatives* / Q000494:pharmacology / Q000627:therapeutic use; D000818:Animals; D000975:Antioxidants / Q000494:pharmacology / Q000627:therapeutic use; D017209:Apoptosis / Q000187:drug effects* / Q000502:physiology; D051017:Apoptosis Regulatory Proteins / Q000187:drug effects / Q000378:metabolism; D019610:Cytoprotection / Q000187:drug effects / Q000502:physiology; D003603:Cytotoxins / Q000037:antagonists & inhibitors / Q000633:toxicity; D004305:Dose-Response Relationship, Drug; D016166:Free Radical Scavengers / Q000378:metabolism; D006861:Hydrogen Peroxide / Q000037:antagonists & inhibitors / Q000633:toxicity; D008928:Mitochondria / Q000187:drug effects / Q000378:metabolism; D009410:Nerve Degeneration / Q000139:chemically induced / Q000188:drug therapy* / Q000378:metabolism; D019636:Neurodegenerative Diseases / Q000188:drug therapy / Q000378:metabolism / Q000503:physiopathology; D009474:Neurons / Q000187:drug effects* / Q000378:metabolism; D018696:Neuroprotective Agents / Q000494:pharmacology* / Q000627:therapeutic use; D018384:Oxidative Stress / Q000187:drug effects* / Q000502:physiology; D016716:PC12 Cells; D051381:Rats; D017382:Reactive Oxygen Species / Q000037:antagonists & inhibitors / Q000378:metabolism; D015854:Up-Regulation / Q000187:drug effects / Q000502:physiology
chemical_list: D000975:Antioxidants; D051017:Apoptosis Regulatory Proteins; D003603:Cytotoxins; D016166:Free Radical Scavengers; D018696:Neuroprotective Agents; D017382:Reactive Oxygen Species; C027820:ligustilide; D006861:Hydrogen Peroxide; D015107:4-Butyrolactone
references: Talanta. 2007 May 15;72(3):1157-65
references: 19071739
references: Biol Pharm Bull. 2007 Feb;30(2):309-12
references: 17268071
references: Arch Neurol. 2000 Sep;57(9):1265-70
references: 10987892
references: Pharmacol Rev. 2002 Jun;54(2):271-84
references: 12037143
references: J Ethnopharmacol. 2007 May 30;112(1):211-4
references: 17350195
references: J Neurochem. 1997 Aug;69(2):514-23
references: 9231709
references: Cell Death Differ. 2002 Sep;9(9):1007-16
references: 12181751
references: J Neurochem. 1992 Nov;59(5):1609-23
references: 1402908
references: Life Sci. 1998;62(23 ):2073-82
references: 9627086
references: Free Radic Biol Med. 1999 Sep;27(5-6):612-6
references: 10490282
references: Ann N Y Acad Sci. 1992 May 11;648:326-7
references: 1322084
references: Brain Res. 2006 Aug 2;1102(1):145-53
references: 16806112
references: J Lab Clin Med. 1992 Jun;119(6):598-620
references: 1593209
references: Free Radic Biol Med. 2007 Mar 1;42(5):675-85
references: 17291991
references: J Neurosci Res. 1996 Jul 1;45(1):1-12
references: 8811508
references: Annu Rev Cell Biol. 1994;10:373-403
references: 7888181
references: Yao Xue Xue Bao. 1984 Aug;19(8):561-5
references: 6536161
references: Pharmacol Ther. 1994;63(1):37-122
references: 7972344
references: Anal Biochem. 1976 May 7;72:248-54
references: 942051
references: J Ethnopharmacol. 2006 Nov 3;108(1):54-8
references: 16730146
references: Immunol Today. 1994 Jan;15(1):7-10
references: 8136014
references: J Neurosci. 2002 Jan 1;22(1):209-17
references: 11756504
references: Toxicol Ind Health. 1993 Jan-Apr;9(1-2):39-51
references: 8380305